Galenicum Annual Report 2020 FIND OUT BELIEVE IN LIFE High quality affordable pharmaceuticals worldwide Galenicum was founded in Barcelona in 2003 with the mission of improving the quality and affordability of pharmaceutical products. This purpose has remained at the core through all these years, while the company has grown to become a global ecosystem of several businesses within the pharmaceutical, food and nutritional supplement sectors. Galenicum covers the entire industry value chain and has commercial agreements in place that span more than forty countries worldwide. Galenicum is continuing its adventure to become a global specialty pharmaceutical company, bringing further innovation to products in the years to come. Business Ecosystem Development, licensing and supply of pharmaceutical products worldwide. Multiple partnership models with other pharmaceutical companies at any stage of the value chain – from R&D right through production and global supply. Broad portfolio of high-quality APIs and pharmaceutical products, covering most therapeutic areas and technologies. See more Manufacturing of pharmaceutical products in multiple formats. State-of-the-art manufacturing facility near Madrid with a production capacity of over 50 million packs per year, and global supply. High-quality Finished Dosage Forms in multiple formats and technologies: liquids, ointments, creams, sachets, powders, nasal sprays, tablets and hard gelatin capsules. See more Sales and distribution of bioequivalent medicines under own brand 'Vitae'. 'Vitae' affiliates in Latin American markets as well as distribution partners across Asia and the Middle East. In-licensing of high-quality Finished Dosage Forms to complete a broad portfolio of pharmaceutical products, covering most therapeutic areas and technologies. See more Sales of specialty dermatological products under own brand 'Galenicum Derma'. Development and in-licensing of innovative and high-quality dermatological products. Sales team based in Spain covering the national market. Considering third-party distribution deals to further enable international expansion. See more Sales of food ingredients, development and sales of food supplements. Trading of raw materials via our sales teams in Spain, France, North Africa, USA and Mexico. Development and supply of innovative food supplements under private labelling worldwide. See more Key Figures 5 Businesses +450 Employees (50-50 men and female) +40 Countries Globally 70% Exports worldwide 120M€ in revenue in 2018 100% Growth by 2024 CONTACT US FOLLOW US AT Copyright © 2021 Galenicum WEBGLN0002-00;10/2019 THIS IS GALENICUM OUR BUSINESS OUR FOOTPRINT WORKING WITH US SOCIAL IMPACT CONTACT US Legal notice Privacy Policy Cookies